Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2020 How Should Clinicians Respond to International Public Health Emergencies? Abbey Lowe, MA, Angela Hewlett, MD, MS, and Toby Schonfeld, PhD Balancing need for global solidarity against local stakeholders’ safety concerns is one source of tension when trying to mitigate global risk. AMA J Ethics. 2020;22(1):E16-21. doi: 10.1001/amajethics.2020.16. Medical Education Jan 2020 Five Things Students and Clinicians Should Know About “Biocontainment” Helen Stanton Chapple, PhD, RN, MSN, MA Being close enough to patients to care is as critical as remaining distant enough from a pathogen to be safe. This strategy simultaneously frustrates and supports public trust. AMA J Ethics. 2020;22(1):E22-27. doi: 10.1001/amajethics.2020.22. Case and Commentary Apr 2006 Changing the Rules in Times of Crisis: Do Desperate Times Allow Desperate Measures? Mona Loutfy, MD, MPH Clinical case examines the ethics of using an experimental drug in treating a patient who is dying from a SARS-like virus. Virtual Mentor. 2006;8(4):214-218. doi: 10.1001/virtualmentor.2006.8.4.ccas4-0604.
Case and Commentary Jan 2020 How Should Clinicians Respond to International Public Health Emergencies? Abbey Lowe, MA, Angela Hewlett, MD, MS, and Toby Schonfeld, PhD Balancing need for global solidarity against local stakeholders’ safety concerns is one source of tension when trying to mitigate global risk. AMA J Ethics. 2020;22(1):E16-21. doi: 10.1001/amajethics.2020.16.
Medical Education Jan 2020 Five Things Students and Clinicians Should Know About “Biocontainment” Helen Stanton Chapple, PhD, RN, MSN, MA Being close enough to patients to care is as critical as remaining distant enough from a pathogen to be safe. This strategy simultaneously frustrates and supports public trust. AMA J Ethics. 2020;22(1):E22-27. doi: 10.1001/amajethics.2020.22.
Case and Commentary Apr 2006 Changing the Rules in Times of Crisis: Do Desperate Times Allow Desperate Measures? Mona Loutfy, MD, MPH Clinical case examines the ethics of using an experimental drug in treating a patient who is dying from a SARS-like virus. Virtual Mentor. 2006;8(4):214-218. doi: 10.1001/virtualmentor.2006.8.4.ccas4-0604.